Children's Hospital Colorado is an academic pediatric acute care children's hospital located in the Anschutz Medical Campus near the interchange of I-225 and Colfax Avenue in Aurora, Colorado. The hospital has 434 pediatric beds at its main campus in Aurora.

There are 434 beds in The Children's Hospital for Cancer and Blood Disorders.

During the past decade, The Children's Hospital for Cancer and Blood Disorders conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Children's Hospital for Cancer and Blood Disorders" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Innovative Therapies for Children with Cancer in Europe (ITCC)" with 1 trials as a collaborator and "New Approaches to Neuroblastoma Therapy Consortium (NANT)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "The Children's Hospital for Cancer and Blood Disorders" are "Infantile Fibrosarcoma" (1 trials), "Infantile Myofibromatosis" (1 trials), "Medullary Thyroid Cancer" (1 trials), "Neoplasm Metastasis" (1 trials) and "Neuroblastoma" (1 trials). Many other conditions were trialed in "The Children's Hospital for Cancer and Blood Disorders" in a lesser frequency.

Most popular intervention types in "The Children's Hospital for Cancer and Blood Disorders" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials), "Ifosfamide" (1 trials), "Irinotecan" (1 trials) and "LOXO-292" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Children's Hospital for Cancer and Blood Disorders" are 3 trials for "All" genders.

Currently, there are NaN active trials in "The Children's Hospital for Cancer and Blood Disorders". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Children's Hospital for Cancer and Blood Disorders, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Children's Hospital for Cancer and Blood Disorders, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".